tiprankstipranks

Comparison Results

Name
Price
Volume
Analyst Price Target
Analyst Consensus
Smart Score
Market Cap
P/E Ratio
Dividend Yield
Sector
Article
Follow
xxxxxxxxxxxxxxxxxxxxxxxxxxx
C$11.13735.90K
C$11.99
(7.70% Upside)
1 Buy
4 Hold
1 Sell
Hold
C$4.09B-16.43Healthcare
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx
C$1.6813.96K
C$5.30
(215.27% Upside)
1 Buy
1 Hold
0 Sell
Moderate Buy
C$77.25M-12.66Healthcare
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxx

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
TSE:BHC
Bausch Health Companies
11.13
1.75
18.66%
TSE:ASP
TSE:TH
Theratechnologies
1.67
-0.35
-17.33%
TSE:BLU
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
Bausch Health Companies
Hold
Reiterated
Theratechnologies
Buy
Upgraded
Bausch Health Companies
Hold
Reiterated
Bausch Health Companies
Hold
Assigned
Bausch Health Companies
Sell
Reiterated
Bausch Health Companies
Hold
Assigned
Theratechnologies
Hold
Downgraded
Bausch Health Companies
Buy
Reiterated
Bausch Health Companies
Sell
Reiterated
Bausch Health Companies
Hold
Initiated

Most Recent Earnings of Biotech Stocks

Name
Report Date
Time Of Day
Period Ending
Forecast / EPS
Last Year's EPS
Bausch Health Companies
Oct 30, 2024
Sep 01, 2024
1.42 / 1.59
1.311
Theratechnologies
Oct 10, 2024
Aug 01, 2024
0.04 / 0.08
-0.08
ASP
- / -
BLU
- / -

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
    Are Biotech stocks overpriced?
    Bausch Health Companies's stock price is currently C$11.13, and its average 12-month price target is C$11.99.
      Theratechnologies's stock price is currently C$1.68, and its average 12-month price target is C$5.30.
        's stock price is currently N/A, and its average 12-month price target is N/A.
          's stock price is currently N/A, and its average 12-month price target is N/A.
            Which Biotech stocks pay dividends?
            Bausch Health Companies does not currently pay dividends.
              Theratechnologies does not currently pay dividends.
                does not currently pay dividends.
                  does not currently pay dividends.